Hyderabad-Based Biophore Pharma Scales Up Production For Favipiravir, Drug For COVID-19 Treatment
After DCGI's Nod, Glenmark Launches Anti-Viral Drug FabiFlu For Treatment Of Mild To Moderate Covid-19 Patients
Glenmark To Begin Phase 3 Clinical Trial On Combo Of Two Antiviral Drugs In Moderate Covid-19 Patients
CSIR Identifies 25 Drugs For Repurposing Against Covid-19, Favipiravir Emerges As Most Promising One
Glenmark Gets DCGI Approval To Conduct Clinical Trials Of Favipiravir Anti-Viral Tablets On Covid-19 Patients
